|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/26/21 Alliance Bioenergy Plus, Inc. 10-K/A 12/31/20 55:3.7M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K/A Amendment to Annual Report HTML 400K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K
12: R1 Document and Entity Information HTML 52K
13: R2 Consolidated Balance Sheets HTML 116K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 36K
15: R4 Consolidated Statement of Operations HTML 71K
16: R5 Consolidated Statements of Stockholders' Equity HTML 77K
17: R6 Consolidated Statements of Stockholders' Equity HTML 23K
(Parenthetical)
18: R7 Consolidated Statements of Cash Flows HTML 94K
19: R8 Organization HTML 22K
20: R9 Going Concern HTML 24K
21: R10 Summary of Significant Accounting Policies HTML 58K
22: R11 Assets HTML 18K
23: R12 Debt HTML 43K
24: R13 Stockholders' Equity HTML 39K
25: R14 Income Taxes HTML 34K
26: R15 Commitments and Contingencies HTML 27K
27: R16 Related Party Transactions HTML 22K
28: R17 Subsequent Events HTML 22K
29: R18 Summary of Significant Accounting Policies HTML 107K
(Policies)
30: R19 Summary of Significant Accounting Policies HTML 32K
(Tables)
31: R20 Debt (Tables) HTML 24K
32: R21 Stockholders' Equity (Tables) HTML 34K
33: R22 Income Taxes (Tables) HTML 35K
34: R23 Commitments and Contingencies (Tables) HTML 25K
35: R24 Organization (Details Narrative) HTML 18K
36: R25 Going Concern (Details Narrative) HTML 23K
37: R26 Summary of Significant Accounting Policies HTML 27K
(Details Narrative)
38: R27 Summary of Significant Accounting Policies - HTML 68K
Schedule of Black-Scholes Option Pricing Models
for Warrant-based Stock Compensation (Details)
39: R28 Assets (Details Narrative) HTML 18K
40: R29 Debt (Details Narrative) HTML 236K
41: R30 Debt - Schedule of Notes Payable (Details) HTML 37K
42: R31 Stockholders' Equity (Details Narrative) HTML 91K
43: R32 Stockholders' Equity - Schedule of Option Activity HTML 62K
(Details)
44: R33 Stockholders' Equity - Schedule of Warrant HTML 57K
Activity (Details)
45: R34 Income Taxes (Details Narrative) HTML 25K
46: R35 Income Taxes - Schedule of Reconciliation Between HTML 26K
Statutory Tax Rate and Effective Tax Rate
(Details)
47: R36 Income Taxes - Schedule of Income Tax Provision HTML 33K
(Details)
48: R37 Income Taxes - Schedule of Tax Effects of HTML 25K
Principal Temporary Differences that Give Rise to
Deferred Tax Assets (Details)
49: R38 Commitments and Contingencies (Details Narrative) HTML 27K
50: R39 Commitments and Contingencies - Schedule of Lease HTML 22K
Consolidated Balance Sheet (Details)
51: R40 Commitments and Contingencies - Schedule of Future HTML 25K
Minimum Lease Payments (Details)
52: R41 Subsequent Events (Details Narrative) HTML 79K
54: XML IDEA XML File -- Filing Summary XML 93K
53: EXCEL IDEA Workbook of Financial Reports XLSX 74K
6: EX-101.INS XBRL Instance -- allm-20201231 XML 881K
8: EX-101.CAL XBRL Calculations -- allm-20201231_cal XML 149K
9: EX-101.DEF XBRL Definitions -- allm-20201231_def XML 403K
10: EX-101.LAB XBRL Labels -- allm-20201231_lab XML 880K
11: EX-101.PRE XBRL Presentations -- allm-20201231_pre XML 620K
7: EX-101.SCH XBRL Schema -- allm-20201231 XSD 130K
55: ZIP XBRL Zipped Folder -- 0001493152-21-009696-xbrl Zip 105K
EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
I, Benjamin Slager, certify that:
| 1. | I have reviewed this Form 10-K/A for the period ended December 31, 2020 of Alliance BioEnergy Plus, Inc.; | |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | ||
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | ||
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | ||
| d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
| 5. | I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | ||
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: April 26, 2021 | |
| /s/ Benjamin Slager | |
| Benjamin Slager | |
| Principal Executive Officer |
C:
| This ‘10-K/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/26/21 | |||
| For Period end: | 12/31/20 | 10-K, NT 10-K, NT 10-K/A | ||
| List all Filings | ||||